MFSD4 (major facilitator superfamily domain containing 4) has been identified as a tumor suppressor of cell motility and invasiveness (by influencing promoter methylation) and a biomarker of hepatic metastasis in gastric cancer (Kanda et al., 2016), correctly identified here as downregulated. Here, SLC60A1 is linked to neoplasm.